Comparison of Human Menopausal Gonadotropins and the Combination of Human Menopausal Gonadotropins With Clomiphene Citrate in Stimulated Intrauterine Insemination Cycles

Sex: Female

Ages: 18 Years – 40 Years

Healthy volunteers: 1

Phase: NA

Enrollment: 254

Sponsor: Bezmialem Vakif University

Summary

The aim of study is to evaluate the results of two different protocols for ovulation induction during IUI cycles. All patients undergo IUI cycles are randomly divided in to two groups. the first group is human menopausal gonadotropins and the second group is the combination of human menopausal gonadotropins with clomiphene citrate

Eligibility Criteria

Inclusion Criteria:18-40 years old femaleUnexplained infertilityRegular menstrual cycleBilateral tubal patency in HSG and normal uterine cavityTotal motile sperm count greater than 10 million/mlExclusion Criteria:History of ovarian surgeryUncorrected uterine pathologyOther endocrine diseases (thyroid, prolactin, hypogonadotropic hypogonadism)Presence of a cyst greater than 10 mm on USG in 2-3 days of the periodStage 3-4 endometriosisTMSS < 5 million/ml on the insemination dayConditions where HMG and clomiphene citrate are contraindicated

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05670795). StuddyBuddy aggregates publicly available trial information.